Verlyx Pharma
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Montreal, Quebec, CanadaWebsite
www.verlyx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About Verlyx Pharma
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Verlyx Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Verlyx Pharma has new funding data
Verlyx Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Verlyx Pharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Verlyx Pharma
Check out if Verlyx Pharma is spiking on competitors!
Check if Verlyx Pharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Verlyx Pharma had a recent Job posting/layoffs
Earning: See what the market has to say on Verlyx Pharma recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Verlyx Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Verlyx Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Verlyx Pharma.
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Verlyx Pharma
Odan Laboratories Ltd. has acquired Verlyx Pharma Inc., a Montreal-based clinical stage biopharmaceutical company, to develop its lead compound VLX103 and its analogs for treating gastrointestinal diseases. The safety and efficacy of these products are still under investigation, and they have not yet received market authorization from Health Canada... Read More
